期刊文献+

蔗糖凝胶治疗细菌性阴道病Ⅱ期临床试验研究 被引量:2

Sucrose Gel for the treatment of bacterial vaginosis:a phase Ⅱ clinical trial
下载PDF
导出
摘要 目的:评价蔗糖凝胶治疗细菌性阴道病的有效剂量及其安全性。方法:采用多中心、随机双盲、剂量组平行对照的临床实验研究方法,对96例细菌性阴道病患者随机分为蔗糖凝胶5.0g组(A组)32例、蔗糖凝胶7.5g组(B组)32例、安慰剂组(C组)32例,按照不同治疗方法进行治疗,并于用药开始第3~4天、用药开始第8天进行疗效观察及安全性评价。结果:临床综合疗效分析显示用药第8天A组治愈率84.38%,B组治愈率86.67%,C组治愈率3.13%。A组和B组治愈率相比,差异无统计学意义,A组和C组治愈率、B组和C组治愈率相比,差异均有统计学意义(P<0.001)。结论:蔗糖凝胶7.5g组与5.0g组患者早晚各一次用药,与安慰剂组凝胶基质相比,可显著改善细菌性阴道病临床疗效指标和实验室指标,具有缓解临床症状、恢复阴道正常微生态环境的作用,而两剂量组治愈率无明显差别。 Objective:To evaluate the effective dose and safety of S-Gel in the treatment of bacterial vaginosis. Methods: Clinical research method of multi-center,randomly double-blind,and dose group parallel comparison was adopted. In the study,96 bacterial vaginosis patients were randomized into three groups: Group A,S-Gel 5.0 g,32 patients; Group B,S-Gel 7.5 g,32 patients; Group C,placebo,32 patients. The patients were treated with different methods. Safety and efficacy were analyzed 3 to 4 days and 8 days after the treatment,respectively. Results: The efficacy of comprehensive clinical treatment showed that: 8 days after the treatment,the cure rates of group A (5.0 g),group B (7.5 g),and group C (placebo) were 84.38%,86.67%,and 3.13% respectively. No difference of statistic significance was found in groups A and B,difference of statistical significance was found in group A and group C,group B and group C respectively (P〈0.001). Conclusion: As compared with placebo,S-Gel 7.5 g and 5.0 g bid (in the morning and evening) could obviously improve the clinical efficacy index and laboratory index of bacterial vaginosis. Other effects included the release of clinical symptoms,and the recovery of the normal micro-environment in the vagina. No significant difference was found in the cure rates of the two dose groups.
出处 《北京大学学报(医学版)》 CAS CSCD 北大核心 2010年第6期746-751,共6页 Journal of Peking University:Health Sciences
关键词 阴道病 细菌性 蔗糖凝胶 有益菌种 临床试验 Ⅱ期 Vaginosis,bacterial; Sucrose gel; Probiotics; Clinical trials,phase Ⅱ;
  • 相关文献

参考文献10

  • 1Moms M,Nicoll A,Simms I,et al.Bacterial vaginosis:a public health reviewl J 1.BJOG,2001,108:439-450.
  • 2Hoyme UB,Huebner J.Prevention of preterm birth is possible by vaginal ph screening,early diagnosis of bacterial vaginosis or abnormal vaginal flora and treatment[J].Gynacol Obstet Invest,2010,70(4):286-290.
  • 3Livengood CH.Bacterial vaginosis:an overvies for 2009[J].Rev Obstet Gynecol,2009,2(1):28-37.
  • 4Wilson J.Managing recurrent bacterial vaginosis[J].Sex Transm Infect,2004,80(1):8-11.
  • 5Sobel JD.Bacterial vaginosisl[J].Annu Bey Med,2000.51(2):349-356.
  • 6Reid G,Bruce AW Urogenital infections in women:Can probiotics help[J].Postgrad Med J,2003,79(934):428-432.
  • 7Reid G,Bruce AW.Probiotics to prevent urinary tract infections:the rationale and evidence[J].World J Urol,2006,24(1):28-32.
  • 8Allswoah JE,Peipert JF.Prevalence of bacterial vaginosis:2001-2004 national health and nutrition examination survey data[J].Obstet Gynecol,2007,109(1):114-120.
  • 9曲陆荣,刘芝芬,富丽,刘勇,王桂荣,孙立梅,矫东风,文姝,袁杰利,康白.乳杆菌活菌胶囊制剂治疗细菌性阴道病62例与灭滴灵对照41例临床效果观察[J].中国微生态学杂志,1999,11(2):90-92. 被引量:3
  • 10王友芳,郎景和,袁杰利,文姝,孙立梅,康白.德氏乳杆菌DM8909菌株对细菌性阴道病治疗的Ⅱ期临床试验研究[J].中国微生态学杂志,2001,13(4):198-199. 被引量:64

二级参考文献7

共引文献65

同被引文献31

  • 1赵瑞,李燕兵,黄菱.苦豆子总碱及四种生物单碱体外触杀阴道毛滴虫的实验研究[J].四川中医,2004,22(11):13-15. 被引量:8
  • 2牟新利 ,王武宝 ,巴杭 ,阿吉艾克拜尔 ,廖立新 .中药苦豆子化学成分及生理活性的研究进展[J].新疆师范大学学报(自然科学版),2005,24(1):45-50. 被引量:36
  • 3樊尚荣,刘小平.细菌性阴道病的研究进展[J].中国妇产科临床杂志,2006,7(3):224-226. 被引量:26
  • 4李炳生,李家仁,王桂梅.离子交换法制备苦豆子总碱注射液[J].中国医院药学杂志,1982,2(1):1-3.
  • 5Lin H R,Sung K C.Carbopol/plurnic phase change solutions for ophthalmic drug delivery[J].J Controlled Release,2000,69(3):379-388.
  • 6Wei G,Xu H,Ding P T,et al.Thermosetting gels with modulated gelation temperature for ophthalmic use,the rheological and gamma scintigraphic studies[J].J Controlled Release,2002,83(1):65-74.
  • 7Bohorquez M,Koch C,Trygstad T,et al.A study of the temperature-dependent micellization of Pluronic F127[J].J Colloid Interface Sci,1999,216(1):34-40.
  • 8Levang A K,Zhao K,Singh J.Effect of ethanol/propylene glycol on the in vitro percutaneous absorption of aspirin,biophysical changes and macroscopic barrier properties of the skin[J].Int J Pharm,1999,181(2):255-263.
  • 9Schwebke JR. New concepts in the etiology of bacterial vaginosis[J]. Curr Infect Dis Rep, 2009, 11(2): 143 -147.
  • 10Danielsson D, Teigen PK, Moi H. The genital econiche: focus onmicrobiota and bacterial vaginosis [ J ] . Ann N Y Acad Sci, 2011,1230 : 48 -58.

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部